We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin Gears Up to Report Q4 Earnings: What's in the Offing?
Read MoreHide Full Article
Key Takeaways
Nu Skin projects Q4 revenues of $365-$400M, suggesting a 10-18% y/y fall.
Nu Skin expects a 1% FX headwind and EPS of 25-35 cents for Q4.
Latin America rose 53% y/y in Q3, while margin expansion and Prysm iO preview may aid Q4.
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to register declines in the top and bottom lines when it reports fourth-quarter 2025 earnings on Feb. 12, after market close. The Zacks Consensus Estimate for revenues is pegged at $382.7 million, suggesting a fall of 14.1% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for quarterly earnings has been unchanged in the past 30 days at 30 cents per share. The projection indicates a decline of 21.1% from the figure reported in the year-ago quarter. The beauty and wellness product company has a trailing four-quarter earnings surprise of 43%, on average. NUS delivered an earnings surprise of 13.3% in the last reported quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
NUS has been operating amid a challenging macroeconomic environment for discretionary beauty and wellness spending. In the third quarter, the company reported year-over-year declines in customers, paid affiliates and sales leaders, reflecting ongoing pressures across several markets.
Management also noted increased competition and crowding within the social commerce beauty space, particularly in North America. Foreign currency is expected to remain a modest headwind. The company projects a 1% adverse FX impact on fourth-quarter revenues.
Against this backdrop, Nu Skin has guided fourth-quarter revenues of $365-$400 million, implying a year-over-year decline of 18-10%. Excluding the prior-year contribution from the divested Mavely business, revenues are expected to fall 12-3%.
Geographically, Latin America has been a bright spot, with revenues up 53% in the third quarter. The company also reported sequential growth in Europe & Africa, the Southeast Asia Pacific, South Korea, and Hong Kong & Taiwan, while noting improving trends in Mainland China. The limited sales leader preview of Prysm iO late in the thirdquarter, along with the commencement of pre-market activities in India, is also expected to have shaped the fourth-quarter performance.
Earnings are likely to have declined year over year due to lower sales and investments tied to upcoming strategic launches. Management expects fourth-quarter earnings per share of 25-35 cents, which implies a decline from adjusted earnings of 38 cents reported in the year-ago period.
However, Nu Skin has delivered five consecutive quarters of adjusted gross margin expansion, supported by product mix improvements and cost discipline, which may provide continued support to profitability.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Nu Skin this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Nu Skin carries a Zacks Rank #3 and has an Earnings ESP of 0.00%.
Stocks With the Favorable Combination
Here are three companies worth considering, as our model shows that these have the right combination to beat on earnings this time around:
Dollar General Corporation (DG - Free Report) currently has an Earnings ESP of +7.37% and a Zacks Rank #2. The Zacks Consensus Estimate for DG’s fourth-quarter fiscal 2025 earnings per share is pegged at $1.57, implying a 6.6% year-over-year decline. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for quarterly revenues is pegged at $10.74 billion, which indicates an increase of 4.3% from the figure reported in the prior-year quarter. Dollar General delivered a trailing four-quarter earnings surprise of 22.9%, on average.
Ulta Beauty, Inc. (ULTA - Free Report) has an Earnings ESP of +1.63% and a Zacks Rank of 3 at present. The consensus estimate for Ulta Beauty’s fourth-quarter fiscal 2025 earnings is pegged at $7.93 per share, implying a decline of 6.3% from the year-ago quarter’s actual.
For Ulta Beauty’s quarterly revenues, the consensus mark is pegged at $3.82 billion, which indicates an increase of 9.6% from the year-ago quarter’s actual. ULTA delivered a trailing four-quarter earnings surprise of 15.7%, on average.
Bath & Body Works, Inc. (BBWI - Free Report) has an Earnings ESP of +0.34% and currently carries a Zacks Rank of 3. BBWI is likely to register a top-line decrease when it reports fourth-quarter fiscal 2025 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $2.60 billion, indicating a 6.8% decline from the figure reported in the prior-year quarter.
The consensus estimate for Bath & Body Works’ earnings is pegged at $1.75 per share, implying a 16.3% decline from the year-ago quarter’s actual. BBWI delivered a negative trailing four-quarter earnings surprise of 1.5%, on average.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Nu Skin Gears Up to Report Q4 Earnings: What's in the Offing?
Key Takeaways
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to register declines in the top and bottom lines when it reports fourth-quarter 2025 earnings on Feb. 12, after market close. The Zacks Consensus Estimate for revenues is pegged at $382.7 million, suggesting a fall of 14.1% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for quarterly earnings has been unchanged in the past 30 days at 30 cents per share. The projection indicates a decline of 21.1% from the figure reported in the year-ago quarter. The beauty and wellness product company has a trailing four-quarter earnings surprise of 43%, on average. NUS delivered an earnings surprise of 13.3% in the last reported quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. price-consensus-eps-surprise-chart | Nu Skin Enterprises, Inc. Quote
Factors Likely to Influence Nu Skin’s Q4 Results
NUS has been operating amid a challenging macroeconomic environment for discretionary beauty and wellness spending. In the third quarter, the company reported year-over-year declines in customers, paid affiliates and sales leaders, reflecting ongoing pressures across several markets.
Management also noted increased competition and crowding within the social commerce beauty space, particularly in North America. Foreign currency is expected to remain a modest headwind. The company projects a 1% adverse FX impact on fourth-quarter revenues.
Against this backdrop, Nu Skin has guided fourth-quarter revenues of $365-$400 million, implying a year-over-year decline of 18-10%. Excluding the prior-year contribution from the divested Mavely business, revenues are expected to fall 12-3%.
Geographically, Latin America has been a bright spot, with revenues up 53% in the third quarter. The company also reported sequential growth in Europe & Africa, the Southeast Asia Pacific, South Korea, and Hong Kong & Taiwan, while noting improving trends in Mainland China. The limited sales leader preview of Prysm iO late in the thirdquarter, along with the commencement of pre-market activities in India, is also expected to have shaped the fourth-quarter performance.
Earnings are likely to have declined year over year due to lower sales and investments tied to upcoming strategic launches. Management expects fourth-quarter earnings per share of 25-35 cents, which implies a decline from adjusted earnings of 38 cents reported in the year-ago period.
However, Nu Skin has delivered five consecutive quarters of adjusted gross margin expansion, supported by product mix improvements and cost discipline, which may provide continued support to profitability.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Nu Skin this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Nu Skin carries a Zacks Rank #3 and has an Earnings ESP of 0.00%.
Stocks With the Favorable Combination
Here are three companies worth considering, as our model shows that these have the right combination to beat on earnings this time around:
Dollar General Corporation (DG - Free Report) currently has an Earnings ESP of +7.37% and a Zacks Rank #2. The Zacks Consensus Estimate for DG’s fourth-quarter fiscal 2025 earnings per share is pegged at $1.57, implying a 6.6% year-over-year decline. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for quarterly revenues is pegged at $10.74 billion, which indicates an increase of 4.3% from the figure reported in the prior-year quarter. Dollar General delivered a trailing four-quarter earnings surprise of 22.9%, on average.
Ulta Beauty, Inc. (ULTA - Free Report) has an Earnings ESP of +1.63% and a Zacks Rank of 3 at present. The consensus estimate for Ulta Beauty’s fourth-quarter fiscal 2025 earnings is pegged at $7.93 per share, implying a decline of 6.3% from the year-ago quarter’s actual.
For Ulta Beauty’s quarterly revenues, the consensus mark is pegged at $3.82 billion, which indicates an increase of 9.6% from the year-ago quarter’s actual. ULTA delivered a trailing four-quarter earnings surprise of 15.7%, on average.
Bath & Body Works, Inc. (BBWI - Free Report) has an Earnings ESP of +0.34% and currently carries a Zacks Rank of 3. BBWI is likely to register a top-line decrease when it reports fourth-quarter fiscal 2025 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $2.60 billion, indicating a 6.8% decline from the figure reported in the prior-year quarter.
The consensus estimate for Bath & Body Works’ earnings is pegged at $1.75 per share, implying a 16.3% decline from the year-ago quarter’s actual. BBWI delivered a negative trailing four-quarter earnings surprise of 1.5%, on average.